Covered recipient · General Payments record
JASPREET S JOHAL
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2024
$1,594.83
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $446.83 | 26 |
| Debt forgiveness | $19.15 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $181.53 | 13 |
| Xeris Pharmaceuticals, Inc. | $45.44 | 2 |
| Neurelis, Inc. | $41.11 | 2 |
| TG THERAPEUTICS, INC. | $41.09 | 2 |
| Lundbeck LLC | $34.75 | 2 |
| Alexion Pharmaceuticals, Inc. | $27.92 | 1 |
| Biogen, Inc. | $25.88 | 1 |
| BAXTER HEALTHCARE | $19.15 | 1 |
| SK Life Science, Inc. | $18.82 | 1 |
| LivaNova USA, Inc. | $16.69 | 1 |
| ARGENX US, INC. | $13.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.58 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998843 | CMS |
| ABBVIE INC. | $12.23 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998845 | CMS |
| ABBVIE INC. | $10.46 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998847 | CMS |
| ABBVIE INC. | $31.11 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998849 | CMS |
| ABBVIE INC. | $11.53 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998851 | CMS |
| ABBVIE INC. | $14.07 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998853 | CMS |
| ABBVIE INC. | $6.66 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998855 | CMS |
| ABBVIE INC. | $33.63 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998857 | CMS |
| ABBVIE INC. | $8.90 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998859 | CMS |
| ABBVIE INC. | $3.00 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998861 | CMS |
| ABBVIE INC. | $12.28 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998863 | CMS |
| ABBVIE INC. | $8.35 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998865 | CMS |
| ABBVIE INC. | $7.73 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998867 | CMS |
| Alexion Pharmaceuticals, Inc. | $27.92 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094008799 | CMS |
| ARGENX US, INC. | $13.60 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142121559 | CMS |
| Baxter Healthcare | $19.15 | 06/21/2024 | Debt forgiveness | Undisputed | 01/23/2026 | 1117802647 | CMS |
| Biogen, Inc. | $25.88 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104858086 | CMS |
| LivaNova USA, Inc. | $16.69 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152796361 | CMS |
| Lundbeck LLC | $18.32 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145929276 | CMS |
| Lundbeck LLC | $16.43 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145929278 | CMS |
| Neurelis, Inc. | $21.83 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145644316 | CMS |
| Neurelis, Inc. | $19.28 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145644318 | CMS |
| SK Life Science, Inc. | $18.82 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154123273 | CMS |
| TG Therapeutics, Inc. | $20.10 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136869940 | CMS |
| TG Therapeutics, Inc. | $20.99 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136870056 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.47 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144598064 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.97 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144598066 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.